Elosulfase alfa for treating mucopolysaccharidosis type 4A

Supporting evidence

• Evaluation report

• Final evaluation determination committee papers (PDF 3.89 MB)

  Published:

  20 April 2022

• Evaluation consultation committee papers (PDF 8.66 MB)

  Published:

  20 April 2022